Page last updated: 2024-08-25

bexarotene and panobinostat

bexarotene has been researched along with panobinostat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Assaf, C; Becker, JC; Dummer, R; Duvic, M; Grazia Bernengo, M; Lebbé, C; Marshood, M; Ortiz Romero, P; Poulalhon, N; Prince, HM; Squier, M; Tai, F; Williams, D	1

Trials

1 trial(s) available for bexarotene and panobinostat

Article	Year
Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: results of a phase II trial. European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:2 Topics: Anticarcinogenic Agents; Antineoplastic Agents; Bexarotene; Disease Progression; Disease-Free Survival; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Male; Middle Aged; Mycosis Fungoides; Panobinostat; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes	2013

Article

Year

Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: results of a phase II trial.

European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:2

Topics: Anticarcinogenic Agents; Antineoplastic Agents; Bexarotene; Disease Progression; Disease-Free Survival; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Male; Middle Aged; Mycosis Fungoides; Panobinostat; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes

2013